Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svatava Snopková

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Vnitrni Lekarstvi|September 22, 2017
[HIV infection - a new disease of internal medicine]Svatava Snopková
Klinicka Mikrobiologie a Infekcni Lekarstvi|February 16, 2022
[Dual or triple combination antiretrovirals?]Petr Husa, Svatava Snopková
Klinicka Mikrobiologie a Infekcni Lekarstvi|October 20, 2006
[Metabolic syndrome and HIV/AIDS disorder]Svatava Snopková, Petr Husa
Vnitrni Lekarstvi|October 12, 2023
Implications of highly suppressive treatment HIV infectionSvatava Snopková, Petr Husa
Klinicka Mikrobiologie a Infekcni Lekarstvi|December 2, 2016
[Tenofovir alafenamide fumarate - a new generation of tenofovir]Svatava Snopková, Kateřina Havlíčková, Petr Husa
Klinicka Mikrobiologie a Infekcni Lekarstvi|December 16, 2020
[Cost-effectiveness analysis for HIV pre-exposure prophylaxis in a high-risk population in the Czech Republic]Jana Skoupá, Karolaacute Švecová, Svatava Snopková
Klinicka Mikrobiologie a Infekcni Lekarstvi|February 16, 2022
[Hepatitis D screening is important in the Czech Republic as well]Petr Husa, Svatava Snopková, Petr Husa
Casopis Lekaru Ceskych|June 21, 2022
Current hepatitis C therapyPetr Husa, Svatava Snopková, Petr Husa Ml
Klinicka Mikrobiologie a Infekcni Lekarstvi|September 3, 2005
[Haemopoiesis defects in HIV/AIDS-anaemia.]Svatava Snopková, Miloslava Matýsková, Petr Husa, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|August 16, 2013
[RILPIVIRINE -- a novel HIV-1 non-nucleoside reverse transcriptase inhibitor]Svatava Snopková, Kateřina Havlíčková, Pavel Polák, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Vnitrni Lekarstvi|September 22, 2017
[HIV infection - a new disease of internal medicine]Svatava Snopková
Klinicka Mikrobiologie a Infekcni Lekarstvi|February 16, 2022
[Dual or triple combination antiretrovirals?]Petr Husa, Svatava Snopková
Klinicka Mikrobiologie a Infekcni Lekarstvi|October 20, 2006
[Metabolic syndrome and HIV/AIDS disorder]Svatava Snopková, Petr Husa
Vnitrni Lekarstvi|October 12, 2023
Implications of highly suppressive treatment HIV infectionSvatava Snopková, Petr Husa
Klinicka Mikrobiologie a Infekcni Lekarstvi|December 2, 2016
[Tenofovir alafenamide fumarate - a new generation of tenofovir]Svatava Snopková, Kateřina Havlíčková, Petr Husa
Klinicka Mikrobiologie a Infekcni Lekarstvi|December 16, 2020
[Cost-effectiveness analysis for HIV pre-exposure prophylaxis in a high-risk population in the Czech Republic]Jana Skoupá, Karolaacute Švecová, Svatava Snopková
Klinicka Mikrobiologie a Infekcni Lekarstvi|February 16, 2022
[Hepatitis D screening is important in the Czech Republic as well]Petr Husa, Svatava Snopková, Petr Husa
Casopis Lekaru Ceskych|June 21, 2022
Current hepatitis C therapyPetr Husa, Svatava Snopková, Petr Husa Ml
Klinicka Mikrobiologie a Infekcni Lekarstvi|September 3, 2005
[Haemopoiesis defects in HIV/AIDS-anaemia.]Svatava Snopková, Miloslava Matýsková, Petr Husa, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|August 16, 2013
[RILPIVIRINE -- a novel HIV-1 non-nucleoside reverse transcriptase inhibitor]Svatava Snopková, Kateřina Havlíčková, Pavel Polák, et al.
Pageof 2